GC Flu Quadrivalent

Bio & Pharma GC Biopharma acquires ABO Holding for $96 mn

South Korea’s GC Biopharma Corp. said on Thursday it acquired the US-based medical-grade source blood plasma company ABO Holding Inc. The...

Bio & Pharma GC establishes generative AI platform Hey GC

South Korea's Green Cross Holdings Corp. (GC) said on Tuesday it established its generative AI standard platform Hey.GC.Hey.GC is designed to improv...

Bio & Pharma SK Bioscience's SKYCellflu approved in Indonesia

SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, said on Wednesday that The Indonesian Food and Drug Authority BPOM ...

Bio & Pharma GC Biopharma sells HK subsidiary to CR Pharm Group for $254 mn

South Korea’s GC Biopharma Corp. announced on Wednesday that it signed a share purchase agreement (SPA) to sell all its shares in its Hong Kon...

Bio & Pharma GC Biopharma exports Alyglo to US

South Korea’s major pharmaceutical company GC Biopharma Corp. announced on Monday that it shipped the initial volume of Alygro, its immunoglob...

Bio & Pharma GC Biopharma aims to boost Alyglo sales sixfold in the US

CHEONGJU, North Chungcheong Province -- South Korea’s major pharmaceutical company GC Biopharma Corp. aims to raise the sales of Alyglo, its i...

Bio & Pharma GC Biopharma gets FDA approval for Alyglo

South Korea’s GC Biopharma Corp. announced on Monday that it received approval from the US Food and Drug Administration (FDA) for the immuno...

Bio & Pharma S.Korea’s GC Cell targets global cell therapy CDMO business

GC Cell Corp., an affiliate of South Korea’s major pharmaceutical company GC Biopharma Corp., is targeting the cell therapy contract developme...

Bio & Pharma GC Biopharma breaks ground on blood product plant in Indonesia

South Korea’s GC Biopharma Corp. broke ground on Wednesday on Indonesia’s first blood product plant through technology transfer.Indonesi...

Bio & Pharma GC Biopharma wins $10 mn order for flu vaccine in Thailand

South Korea's GC Biopharma Corp. announced on Thursday that its flu vaccine GC Flu secured a $10 million order in the upcoming bid by Thailand's Gov...

Bio & Pharma EuBiologics, GC Biopharma to jointly produce cholera vaccine

South Korea's EuBiologics Co., the world's leading cholera vaccine company, has signed a joint production agreement with GC Biopharma Corp. to produ...

Bio & Pharma SK Bioscience resumes output of flu vaccine after two years

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, on Wednesday shipped SKYCellflu, its vaccine for the common flu, for the fi...

Bio & Pharma SK Bioscience to export $51 bn flu vaccine to Thailand

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a deal with Thailand's state-owned G...

Bio & Pharma GC Biopharma wins approval for quadrivalent flu vaccine in Egypt

South Korea's GC Biopharma Corp. announced on Wednesday that its quadrivalent influenza vaccine "GC Flu Quadrivalent" has received approval from Egy...

Bio & Pharma GC Biopharma inks $90mn deal for blood products in Brazil

South Korea's GC Biopharma Corp. on Monday announced on Monday that it has a supply contract with Blau Farmacêutica, a Brazilian pharmaceutica...

Bio & Pharma S.Korea's SK Bioscience to resume domestic flu vaccine output

South Korea's SK Bioscience Co. will resume making domestic flu vaccines by year's end, two years after it stopped production to supply a vaccine fo...

Bio & Pharma GC Biopharma wins contract to build blood products plant in Indonesia

GC Biopharma Corp., a South Korean pharmaceutical company, announced on Thursday that it has received approval from the Indonesian Ministry of Healt...

Bio & Pharma GC Biopharma wins $44 mn flu vaccine order from WHO agency

South Korea's pharmaceutical firm GC Biopharma Corp. said on Monday that it has won a $44.3 million (57.9 billion won) order for flu vaccines in a d...

Bio & Pharma GC Biopharma's licensed flu vaccine gets approval in Taiwan

South Korea's pharmaceutical firm GC Biopharma Corp. announced on Monday that its quadrivalent flu vaccine has received marketing approval from the ...

Bio & Pharma GC Biopharma to develop mRNA flu vaccine with Canadian pharma

South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The dr...

Bio & Pharma GC Biopharma introduces candidates for treating blood coagulation disease

South Korea's GC Biopharma Corp. announced on Tuesday that it had entered into an agreement to transfer assets with Catalyst Biosciences, a US-based...

Bio & Pharma GC Biopharma gets WHO pre-qualification approval for chickenpox vaccine

South Korea's GC Biopharma Corp. is set to regain the No. 1 spot in global production of chickenpox vaccines after earning qualification to enter th...

Bio & Pharma GC Biopharma, Sanofi to jointly market Plavix

GC Biopharma Co. (formerly Green Cross Corp.) said on Monday it has entered into a joint sales partnership with Sanofi-Aventis Korea, the South Kore...

Bio & Pharma GC Biopharma's Ochang facility gets WHO PQ certification

GC Biopharma Co.'s production facility in Ochang (North Chungcheong Province) secured a pre-qualification (PQ) certification from the World Health O...

Bio & Pharma Red ginseng prevents flu, pneumonia: research

Studies have shown that South Korea's hongsam (red ginseng) is effective in preventing respiratory diseases such as the flu and pneumonia.The Korean...

Bio & Pharma GC Cell's AB-101 NK therapy achieves FDA fast-track status

South Korea's bio firm GC Cell announced on Wednesday that its US affiliate Artiva Biotherapeutics has received fast-track designation from the US F...

Bio & Pharma GC Biopharma's Sanfilippo treatment eligible for FDA priority review

GC Biopharma Corp. said on Wednesday that its Sanfilippo type A treatment, which is under joint development with Novel Pharma, a bio-venture special...

Bio & Pharma GC Biopharma confirms safety of flu vaccine in phase 1 trial

South Korea's leading pharmaceutical company GC Biopharma Corp. said on Thursday that it has confirmed the safety and immunogenicity of the patch-ty...

Bio & Pharma Korea's SD Biosensor to supply diagnostics kits to Japan in H2

SD Biosensor Inc., South Korea’s leading in-vitro diagnostics company, has signed an agreement to supply its COVID-19 self-test kits and other...

Korean startups Five startups join the ranks of unicorns in the first half of this year

Five South Korean startups joined the ranks of unicorns in the first half of 2022, the largest such figure for six months. With that, the total...